🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well nemtabrutinib in combination with pembro...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-08-15
Trial ID
NCT06863402
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This phase I trial studies the side effects and best dose of ziv-aflibercep...
Status
Active Not Recruiting
Location
Moffitt Cancer Center-International Plaza
Start Date
2015-04-08
Trial ID
NCT02298959
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This phase II trial studies how well pembrolizumab and epacadostat work in ...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-12-21
Trial ID
NCT03602586
Treatments Being Tested
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067
This is an open-label, multicenter Phase II clinical study aimed at evaluat...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06
Trial ID
NCT06942767
Treatments Being Tested
This phase II trial compares the effect of adding ipatasertib to pembrolizu...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-07-26
Trial ID
NCT05172258
Treatments Being Tested
This randomized phase II trial studies how well pembrolizumab with or witho...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-06-12
Trial ID
NCT03304639
Treatments Being Tested